Therapeuticsmd Inc (TXMD) 4.70 $TXMD
TherapeuticsMD prices common stock offering at USD4.05 per share
M2 - Thu Feb 12, 4:46AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) said on Wednesday that it has priced its public offering of 13.6m shares of its common stock.
TXMD: 4.70 (-0.09)
TherapeuticsMD (TXMD) Stock Surges Today After Pricing Public Offering
at The Street - Wed Feb 11, 11:41AM CST
Shares of TherapeuticsMD (TXMD) are up on heavy trading volume after the company priced approximately 13.6 million shares of its common stock at $4.05 per share.
TXMD: 4.70 (-0.09)
TherapeuticsMD prices equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:55AM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Pricing of Common Stock Offering
Business Wire - Wed Feb 11, 7:01AM CST
TherapeuticsMD, Inc. (NYSE MKT: TXMD) today announced the pricing of an underwritten public offering of approximately 13.6 million shares of its common stock, offered at a price of $4.05 per share. The gross proceeds to TherapeuticsMD from this offering are expected to be approximately $55.0 million, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD. In addition, TherapeuticsMD has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to approximately 2.0 million additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is expected to close on or about February 17, 2015, subject to the satisfaction of customary closing conditions.
TXMD: 4.70 (-0.09)
TherapeuticsMD to issue common stock in public offering
M2 - Wed Feb 11, 4:12AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) said on Tuesday that it plans to start an underwritten public offering of shares of its common stock.
TXMD: 4.70 (-0.09)
TherapeuticsMD initiates equity offering
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:28PM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Offering of Common Stock
Business Wire - Tue Feb 10, 3:01PM CST
TherapeuticsMD, Inc. (NYSE MKT:TXMD) today announced the launch of an underwritten public offering of shares of its common stock. TherapeuticsMD also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock to cover overallotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
TXMD: 4.70 (-0.09)
5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More
at The Street - Fri Jan 23, 12:09PM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
LGCY: 13.35 (+0.51), TXMD: 4.70 (-0.09), CPRX: 3.36 (-0.10), REXX: 5.08 (+0.13), COCO: 0.02 (-0.01)
Sonus Networks Is a Top Stock Under $10 for 2015, David Peltier
at The Street - Fri Jan 02, 9:09AM CST
Portfolio Manager David Peltier highlights Sonus Networks as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), COT: 7.94 (unch), SONS: 17.69 (-0.01), BTN: 4.30 (+0.12)
Cott Corp. Is a Top Stock Under $10 for 2015, Says Peltier
at The Street - Wed Dec 31, 9:08AM CST
Portfolio Manager David Peltier highlights Cott Corp. as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), COT: 7.94 (unch), BTN: 4.30 (+0.12)
Pacific Sunwear Is a Top Stock Under $10 for 2015, Says Peltier
at The Street - Tue Dec 30, 8:10AM CST
Portfolio Manager David Peltier highlights Pacific Sunwear as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), ANF: 26.08 (+0.85), AEO: 14.68 (-0.12), BTN: 4.30 (+0.12), ARO: 3.63 (+0.04)
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier
at The Street - Mon Dec 29, 9:35AM CST
Here's why the stock may blossom.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), TXMD: 4.70 (-0.09), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BTN: 4.30 (+0.12)
TherapeuticsMD wins five new US patent allowances for development of investigational bio-identical hormone therapy products for women
M2 - Tue Dec 16, 5:53AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) reported on Monday the receipt of five new allowances for patents related to its proprietary SYMBODA technology platform from the US Patent and Trademark Office (USPTO).
TXMD: 4.70 (-0.09)
TherapeuticsMD Receives Five New Patent Allowances, Further Strengthens IP Assets
Business Wire - Mon Dec 15, 3:15PM CST
TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced the U.S. Patent and Trademark Office (USPTO) has approved five new allowances for patents related to the company's proprietary SYMBODA(TM) technology platform.
TXMD: 4.70 (-0.09)
TherapeuticsMD (TXMD) Is Today's Strong On High Volume Stock
at The Street - Fri Dec 05, 9:05AM CST
Trade-Ideas LLC identified TherapeuticsMD (TXMD) as a strong on high relative volume candidate
TXMD: 4.70 (-0.09)
TherapeuticsMD Inc. to present at the Stifel Healthcare Conference
Business Wire - Fri Nov 14, 3:15PM CST
TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced CEO Robert G. Finizio will present an overview of the company at the Stifel 2014 Healthcare Conference, Tuesday, November 18 at 8 a.m. EST at the New York Palace Hotel.
TXMD: 4.70 (-0.09)
TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Nov 09, 4:29AM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD misses by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:24PM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Third Quarter Financial Results
Business Wire - Thu Nov 06, 3:06PM CST
--Sales increased by 82 percent over prior year period
TXMD: 4.70 (-0.09)
TherapeuticsMD reports November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 5:51PM CDT
TXMD: 4.70 (-0.09)
TherapeuticsMD prices common stock offering at USD4.05 per share
M2 - Thu Feb 12, 4:46AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) said on Wednesday that it has priced its public offering of 13.6m shares of its common stock.
TXMD: 4.70 (-0.09)
TherapeuticsMD (TXMD) Stock Surges Today After Pricing Public Offering
at The Street - Wed Feb 11, 11:41AM CST
Shares of TherapeuticsMD (TXMD) are up on heavy trading volume after the company priced approximately 13.6 million shares of its common stock at $4.05 per share.
TXMD: 4.70 (-0.09)
TherapeuticsMD prices equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:55AM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Pricing of Common Stock Offering
Business Wire - Wed Feb 11, 7:01AM CST
TherapeuticsMD, Inc. (NYSE MKT: TXMD) today announced the pricing of an underwritten public offering of approximately 13.6 million shares of its common stock, offered at a price of $4.05 per share. The gross proceeds to TherapeuticsMD from this offering are expected to be approximately $55.0 million, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD. In addition, TherapeuticsMD has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to approximately 2.0 million additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is expected to close on or about February 17, 2015, subject to the satisfaction of customary closing conditions.
TXMD: 4.70 (-0.09)
TherapeuticsMD to issue common stock in public offering
M2 - Wed Feb 11, 4:12AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) said on Tuesday that it plans to start an underwritten public offering of shares of its common stock.
TXMD: 4.70 (-0.09)
TherapeuticsMD initiates equity offering
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:28PM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Offering of Common Stock
Business Wire - Tue Feb 10, 3:01PM CST
TherapeuticsMD, Inc. (NYSE MKT:TXMD) today announced the launch of an underwritten public offering of shares of its common stock. TherapeuticsMD also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock to cover overallotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
TXMD: 4.70 (-0.09)
5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More
at The Street - Fri Jan 23, 12:09PM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
LGCY: 13.35 (+0.51), TXMD: 4.70 (-0.09), CPRX: 3.36 (-0.10), REXX: 5.08 (+0.13), COCO: 0.02 (-0.01)
Sonus Networks Is a Top Stock Under $10 for 2015, David Peltier
at The Street - Fri Jan 02, 9:09AM CST
Portfolio Manager David Peltier highlights Sonus Networks as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), COT: 7.94 (unch), SONS: 17.69 (-0.01), BTN: 4.30 (+0.12)
Cott Corp. Is a Top Stock Under $10 for 2015, Says Peltier
at The Street - Wed Dec 31, 9:08AM CST
Portfolio Manager David Peltier highlights Cott Corp. as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), COT: 7.94 (unch), BTN: 4.30 (+0.12)
Pacific Sunwear Is a Top Stock Under $10 for 2015, Says Peltier
at The Street - Tue Dec 30, 8:10AM CST
Portfolio Manager David Peltier highlights Pacific Sunwear as one of his top stocks under $10 for 2015.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), PSUN: 2.95 (unch), TXMD: 4.70 (-0.09), ANF: 26.08 (+0.85), AEO: 14.68 (-0.12), BTN: 4.30 (+0.12), ARO: 3.63 (+0.04)
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier
at The Street - Mon Dec 29, 9:35AM CST
Here's why the stock may blossom.
SON: 46.65 (-0.79), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), TMP: 52.45 (-0.30), TXMD: 4.70 (-0.09), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BTN: 4.30 (+0.12)
TherapeuticsMD wins five new US patent allowances for development of investigational bio-identical hormone therapy products for women
M2 - Tue Dec 16, 5:53AM CST
Healthcare company TherapeuticsMD (NYSE MKT:TXMD) reported on Monday the receipt of five new allowances for patents related to its proprietary SYMBODA technology platform from the US Patent and Trademark Office (USPTO).
TXMD: 4.70 (-0.09)
TherapeuticsMD Receives Five New Patent Allowances, Further Strengthens IP Assets
Business Wire - Mon Dec 15, 3:15PM CST
TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced the U.S. Patent and Trademark Office (USPTO) has approved five new allowances for patents related to the company's proprietary SYMBODA(TM) technology platform.
TXMD: 4.70 (-0.09)
TherapeuticsMD (TXMD) Is Today's Strong On High Volume Stock
at The Street - Fri Dec 05, 9:05AM CST
Trade-Ideas LLC identified TherapeuticsMD (TXMD) as a strong on high relative volume candidate
TXMD: 4.70 (-0.09)
TherapeuticsMD Inc. to present at the Stifel Healthcare Conference
Business Wire - Fri Nov 14, 3:15PM CST
TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced CEO Robert G. Finizio will present an overview of the company at the Stifel 2014 Healthcare Conference, Tuesday, November 18 at 8 a.m. EST at the New York Palace Hotel.
TXMD: 4.70 (-0.09)
TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Nov 09, 4:29AM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD misses by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:24PM CST
TXMD: 4.70 (-0.09)
TherapeuticsMD Announces Third Quarter Financial Results
Business Wire - Thu Nov 06, 3:06PM CST
--Sales increased by 82 percent over prior year period
TXMD: 4.70 (-0.09)
TherapeuticsMD reports November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 5:51PM CDT
TXMD: 4.70 (-0.09)
